At bluebird bio, we’re pushing hard on gene therapy because we believe it delivers the chance for people with severe genetic diseases and cancer to live fully, regardless of what’s written in their DNA. We’re doing the hard work because people facing these challenges deserve it. Our goal is to recode the science, the system – and even the status quo – for life. We are 800+ employees across the US & Europe who care de...
At bluebird bio, we’re pushing hard on gene therapy because we believe it delivers the chance for people with severe genetic diseases and cancer to live fully, regardless of what’s written in their DNA. We’re doing the hard work because people facing these challenges deserve it. Our goal is to recode the science, the system – and even the status quo – for life. We are 800+ employees across the US & Europe who care deeply and challenge convention to help the people who need us. We are working toward four potential product approvals by 2022 and a pipeline ready to tackle a range of severe diseases.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.